Sercan Yilmaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sercan Yilmaz has a total of 195 co-authors. Here are the top co-authors by number of shared publications:
- Engin Kaya
Gulhane Training and Research Hospital, Turkey
17 shared publications - Lutfi Tunc
Department of Urology, Gazi University School of Medicine, Ankara, Turkey
12 shared publications - Eymen Gazel
Acıbadem University Ankara Hospital, Department of Urology, Ankara, Turkey
11 shared publications - Serdar Yalçın
Department of Urology, Gülhane Training and Research Hospital, Health Sciences University, Ankara, Turkey
11 shared publications - Halil Cagri Aybal
Kahramankazan Hamdi Eris State Hospital, Department of Urology, Ankara, Turkey
9 shared publications - Mehmet Yilmaz
Urology, MediClin Kraichgau-Klinik, Bad Rappenau, Germany
7 shared publications
Latest Publications
- Open Access
- 14 October 2025
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 55 (5) , 1213-1219
Efficacy and safety of low-power holmium laser enucleation of the prostate: experience gained from more than 700 cases
Background/aim: The aim of this study was to investigate the functional outcomes, safety, and effectiveness of low-power (LP) holmium laser enucleation of the prostate (HoLEP) using a 37.5 W holmium laser source. Materials and methods: We retrospectively reviewed 713 patients with a diagnosis of benign prostatic hyperplasia (BPH) treated with HoLEP using an LP setting (37.5 W laser set to 1.5 J with a frequency of 25 Hz). All procedures were performed by experienced urologists. Functional outcomes, perioperative parameters, and complications were assessed over a 12-month follow-up period. Effect sizes (Cohen’s d) and 95% confidence intervals (CI) were calculated to evaluate the magnitude and precision of changes in maximum urinary flow rate (Qmax), postvoiding residual volume (PVR), international prostate symptoms score (I-PSS), and other parameters. Results: The mean (SD) preoperative serum PSA level was 4.8 ng/mL (3.6), and the mean prostate volume was 94.02 mL (55.35). The average enucleation time was 72.42 min (32.36), morcellation time was 10.35 min (8.62), and total operation time was 82.74 min (38.08). At 1 month after the surgery, significant improvements were observed in I-PSS (from 25.01 (7.62) to 11.02 (5.3), Cohen’s d = 2.08, 95% CI 1.91–2.25), Qmax (from 10.7 (4.28) to 18.68 (9.52) mL/s, d = 1.08, 95% CI 0.93–1.22), and PVR (from 139.38 (18.07) to 24.85 (18.07) mL, d = 3.13, 95% CI 2.87–3.39), all with p < 0.001. Transfusion was required in 23 patients (3.2%) and early reoperation in 14 patients (2%). Stress urinary incontinence occurred in 11 patients (1.5%) during late follow-up but was resolved in all cases by the 6th month. These outcomes support the safety and efficacy of LP HoLEP, yielding results comparable to those reported with high-power (HP) laser techniques in the literature. Conclusions: In this retrospective study, we showed that LP HoLEP can be performed safely and effectively, similar to other enucleation methods; however, further studies are necessary to validate its acceptance as a viable alternative to HP HoLEP.
- 14 October 2025
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 55 (5) , 1213-1219
Open AccessEfficacy and safety of low-power holmium laser enucleation of the prostate: experience gained from more than 700 cases
Background/aim: The aim of this study was to investigate the functional outcomes, safety, and effectiveness of low-power (LP) holmium laser enucleation of the prostate (HoLEP) using a 37.5 W holmium laser source. Materials and methods: We retrospectively reviewed 713 patients with a diagnosis of benign prostatic hyperplasia (BPH) treated with HoLEP using an LP setting (37.5 W laser set to 1.5 J with a frequency of 25 Hz). All procedures were performed by experienced urologists. Functional outcomes, perioperative parameters, and complications were assessed over a 12-month follow-up period. Effect sizes (Cohen’s d) and 95% confidence intervals (CI) were calculated to evaluate the magnitude and precision of changes in maximum urinary flow rate (Qmax), postvoiding residual volume (PVR), international prostate symptoms score (I-PSS), and other parameters. Results: The mean (SD) preoperative serum PSA level was 4.8 ng/mL (3.6), and the mean prostate volume was 94.02 mL (55.35). The average enucleation time was 72.42 min (32.36), morcellation time was 10.35 min (8.62), and total operation time was 82.74 min (38.08). At 1 month after the surgery, significant improvements were observed in I-PSS (from 25.01 (7.62) to 11.02 (5.3), Cohen’s d = 2.08, 95% CI 1.91–2.25), Qmax (from 10.7 (4.28) to 18.68 (9.52) mL/s, d = 1.08, 95% CI 0.93–1.22), and PVR (from 139.38 (18.07) to 24.85 (18.07) mL, d = 3.13, 95% CI 2.87–3.39), all with p < 0.001. Transfusion was required in 23 patients (3.2%) and early reoperation in 14 patients (2%). Stress urinary incontinence occurred in 11 patients (1.5%) during late follow-up but was resolved in all cases by the 6th month. These outcomes support the safety and efficacy of LP HoLEP, yielding results comparable to those reported with high-power (HP) laser techniques in the literature. Conclusions: In this retrospective study, we showed that LP HoLEP can be performed safely and effectively, similar to other enucleation methods; however, further studies are necessary to validate its acceptance as a viable alternative to HP HoLEP.
- 29 November 2024
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-7
Endoscopic holmium laser harvesting of bladder mucosal graft for urethroplasty: retrospective analysis of single center preliminary results
Purpose Urethral stricture disease (USD) incidence is estimated to be as high as 0.6–1.2%. In 2022, it was published that the bladder mucosal graft to be used in urethroplasty can be obtained endoscopically with a holmium laser. We aimed to present our single center graft urethroplasty results obtained with the endoscopic holmium laser harvesting of bladder mucosal graft technique. Methods We retrospectively reviewed the results of patients who underwent bladder mucosal graft (BlMG) urethroplasty by single surgeon at our center hospital between December 2022 and May 2023. Results A total of 14 patients underwent BlMG urethroplasty surgery. Of them 8 were male and 6 were female patients. The mean patient age was 53 (range 26–76) years. The mean length of stricture was 4,35 (range 1–11) cm. The maximum postoperative flow rate was < 10 ml/sec in three of the 14 patients. Conclusion To our knowledge this is the first study investigating the preliminary results of substitution urethroplasties that is performed with bladder mucosal grafts harvested with laser energy via transurethral (endoscopic) route. Though more work is needed to better understand its current role in complex urethral reconstruction, our patient cohort will be a niche for further studies.
- 29 November 2024
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-7
Endoscopic holmium laser harvesting of bladder mucosal graft for urethroplasty: retrospective analysis of single center preliminary results
Purpose Urethral stricture disease (USD) incidence is estimated to be as high as 0.6–1.2%. In 2022, it was published that the bladder mucosal graft to be used in urethroplasty can be obtained endoscopically with a holmium laser. We aimed to present our single center graft urethroplasty results obtained with the endoscopic holmium laser harvesting of bladder mucosal graft technique. Methods We retrospectively reviewed the results of patients who underwent bladder mucosal graft (BlMG) urethroplasty by single surgeon at our center hospital between December 2022 and May 2023. Results A total of 14 patients underwent BlMG urethroplasty surgery. Of them 8 were male and 6 were female patients. The mean patient age was 53 (range 26–76) years. The mean length of stricture was 4,35 (range 1–11) cm. The maximum postoperative flow rate was < 10 ml/sec in three of the 14 patients. Conclusion To our knowledge this is the first study investigating the preliminary results of substitution urethroplasties that is performed with bladder mucosal grafts harvested with laser energy via transurethral (endoscopic) route. Though more work is needed to better understand its current role in complex urethral reconstruction, our patient cohort will be a niche for further studies.
- 30 October 2024
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 58 (4) , 366-379
Komplike Olmayan Üriner Sistem Enfeksiyonlarında Lokal Antibiyotik Direncinin Çok Merkezli Taranması: 37 Merkezden 1850 Hasta
Study demonstrated that antibiotic resistance in the treatment of uncomplicated urinary tract infections varies by geographical region. We believe this comprehensive, national prospective study will provide valuable insights for clinicians planning empirical treatment for uncomplicated urinary tract infections.
- 30 October 2024
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 58 (4) , 366-379
Komplike Olmayan Üriner Sistem Enfeksiyonlarında Lokal Antibiyotik Direncinin Çok Merkezli Taranması: 37 Merkezden 1850 Hasta
Study demonstrated that antibiotic resistance in the treatment of uncomplicated urinary tract infections varies by geographical region. We believe this comprehensive, national prospective study will provide valuable insights for clinicians planning empirical treatment for uncomplicated urinary tract infections.
- 8 July 2023
- Published by Springer Nature in World Journal of Urology
- Vol. 41 (9) , 2303-2309
A Delphi consensus to standardize the technique of anatomical endoscopic enucleation of prostate: a study by ESUT endoscopic enucleation of prostate study group
Purpose Our objective was to establish a standardized technique for Anatomical Endoscopic Enucleation of Prostate (AEEP) utilizing a consensus statement to provide robust recommendations for urologists who are new to this procedure. Methods The participants were electronically sent a questionnaire in three consecutive rounds. In the second and third rounds, the anonymous aggregate results of the previous round were presented. Experts’ feedback and comments were then incorporated to refine existing questions or to explore more controversial topics in greater depth. Results Forty-one urologists participated in the first round. In the second round, all Round 1 participants received a 22-question survey, resulting in a consensus on 21 items. In the third round, 76% (19/25) of the second-round respondents also participated, reaching a consensus on 22 additional items. The panelists consensually agreed on detaching the urethral sphincter at the beginning of the enucleation and not at the end of the enucleation. To prevent incontinence, it was recommended that the apical mucosa be preserved through various approaches between 11 and 1 o’clock while gently disrupting the lateral lobes in their apical part, avoiding an excess energy delivery approximation to the apical mucosa. Conclusion To optimize laser AEEP procedures, urologists must follow expert guidelines on equipment and surgical technique, including early apical release, using the 3-lobe technique for enucleation, preserving apical mucosa with appropriate approaches, gently disrupting lateral lobes at their apical regions, and avoiding excessive energy delivery near the apical mucosa. Following these recommendations can lead to improved outcomes and patient satisfaction.
- 8 July 2023
- Published by Springer Nature in World Journal of Urology
- Vol. 41 (9) , 2303-2309
A Delphi consensus to standardize the technique of anatomical endoscopic enucleation of prostate: a study by ESUT endoscopic enucleation of prostate study group
Purpose Our objective was to establish a standardized technique for Anatomical Endoscopic Enucleation of Prostate (AEEP) utilizing a consensus statement to provide robust recommendations for urologists who are new to this procedure. Methods The participants were electronically sent a questionnaire in three consecutive rounds. In the second and third rounds, the anonymous aggregate results of the previous round were presented. Experts’ feedback and comments were then incorporated to refine existing questions or to explore more controversial topics in greater depth. Results Forty-one urologists participated in the first round. In the second round, all Round 1 participants received a 22-question survey, resulting in a consensus on 21 items. In the third round, 76% (19/25) of the second-round respondents also participated, reaching a consensus on 22 additional items. The panelists consensually agreed on detaching the urethral sphincter at the beginning of the enucleation and not at the end of the enucleation. To prevent incontinence, it was recommended that the apical mucosa be preserved through various approaches between 11 and 1 o’clock while gently disrupting the lateral lobes in their apical part, avoiding an excess energy delivery approximation to the apical mucosa. Conclusion To optimize laser AEEP procedures, urologists must follow expert guidelines on equipment and surgical technique, including early apical release, using the 3-lobe technique for enucleation, preserving apical mucosa with appropriate approaches, gently disrupting lateral lobes at their apical regions, and avoiding excessive energy delivery near the apical mucosa. Following these recommendations can lead to improved outcomes and patient satisfaction.
- Open Access
- 1 January 2023
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 49 (4) , 225-232
Management of Priapism: Results of a Nationwide Survey and Comparison with International Guidelines
Objective: The aim of this study is to evaluate current urologic practice regarding the management of priapism in Turkey and compare with international guidelines. Methods: Urologists and urology residents were invited to an online survey consisting of 30 multiple-choice questions on priapism-related clinical practices that were consid- ered most important and relevant to practices by using Google Forms. Results: Total number of responses was 340. Respondents reported that they recorded a detailed patient’s medical history and physical examination findings (n = 340, 100%) and laboratory testing, which includes corporal blood gas analysis (n=323, 95%). Participants announced that they performed Doppler ultrasound for 1/4 cases (n = 106, 31%), but 22% of the participants (n=75) replied that they performed in >75% of cases. Participants (n=311, 91%) responded that the first-line treatment of ischemic priapism is decompression of the corpus cavernosum. Moreover, most respondents (n = 320, 94%) stated that sympathomimetic injection drugs should be applied as the second step. About three-quarters of respondents (n = 247, 73%) indicated adrenaline as their drug of choice. Phosphodiesterase type 5 inhibitors seems to be the most pre- ferred drug for stuttering priapism (n=141, 41%). Participants (n=284, 84%) replied that corpora-glanular shunts should be preferred as the first. A large number of par- ticipants (n = 239, 70%) declared that magnetic resonance imaging can be performed in cases with delayed (>24 hours) priapism to diagnose corporal necrosis. Most of the participants (84%) responded that penile prosthesis should be preferred to shunts in cases with delayed (>48 hours) priapism. Conclusion: It would be appropriate to improve the training offered by professional associations and to give more training time to the management of priapism during residency. Cite this article as: Kalkanli A, Zeki Sönmez S, Guvel M, et al. Management of priapism: Results of a nationwide survey and comparison with international guidelines. Urol Res Pract. 2023;49(4):225-232.
- 1 January 2023
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 49 (4) , 225-232
Open AccessManagement of Priapism: Results of a Nationwide Survey and Comparison with International Guidelines
Objective: The aim of this study is to evaluate current urologic practice regarding the management of priapism in Turkey and compare with international guidelines. Methods: Urologists and urology residents were invited to an online survey consisting of 30 multiple-choice questions on priapism-related clinical practices that were consid- ered most important and relevant to practices by using Google Forms. Results: Total number of responses was 340. Respondents reported that they recorded a detailed patient’s medical history and physical examination findings (n = 340, 100%) and laboratory testing, which includes corporal blood gas analysis (n=323, 95%). Participants announced that they performed Doppler ultrasound for 1/4 cases (n = 106, 31%), but 22% of the participants (n=75) replied that they performed in >75% of cases. Participants (n=311, 91%) responded that the first-line treatment of ischemic priapism is decompression of the corpus cavernosum. Moreover, most respondents (n = 320, 94%) stated that sympathomimetic injection drugs should be applied as the second step. About three-quarters of respondents (n = 247, 73%) indicated adrenaline as their drug of choice. Phosphodiesterase type 5 inhibitors seems to be the most pre- ferred drug for stuttering priapism (n=141, 41%). Participants (n=284, 84%) replied that corpora-glanular shunts should be preferred as the first. A large number of par- ticipants (n = 239, 70%) declared that magnetic resonance imaging can be performed in cases with delayed (>24 hours) priapism to diagnose corporal necrosis. Most of the participants (84%) responded that penile prosthesis should be preferred to shunts in cases with delayed (>48 hours) priapism. Conclusion: It would be appropriate to improve the training offered by professional associations and to give more training time to the management of priapism during residency. Cite this article as: Kalkanli A, Zeki Sönmez S, Guvel M, et al. Management of priapism: Results of a nationwide survey and comparison with international guidelines. Urol Res Pract. 2023;49(4):225-232.
- 21 February 2022
- Published by Pera Yayıncılık Hizmetleri in Yeni Üroloji Dergisi
- Vol. 17 (1) , 6-13
Hawk® JAWS versus Lumenis® VersaCut prostate morcellation devices: A comparative study and comprehensive literature review
Objective: Although morcellation is a standard procedure of Holmium Laser Enucleation of the Prostate (HoLEP), studies on the morcellators used are limited in number. We aimed to compare two different tissue morcellators used in HoLEP, which have similar objectives but differences in efficiency and safety in working principles. Material and Methods: The data of 130 patients who underwent HoLEP between December 2018 and December 2019 were retrospectively reviewed. Sixty-five patients received Lumenis® Versacut (Lumenis Inc., Santa Clara, CA, USA) morcellator and 65 patients received Hawk® JAWS (Hawk, Minitech Co., China) morcellator after enucleation were included in the study. The efficiency of morcellation (g/min), morcellation time (min), total operation time (min), enucleation time (min), enucleated tissue weight (g), the efficiency of enucleation, densities of the removed prostate tissues, perioperative complications associated with the use of a morcellator were recorded perioperatively. Results: There was no significant difference in total operation time (min), enucleation time (min), enucleated tissue weight (g), and efficiency of enucleation (g/min) efficiency of morcellation, morcellation time (min) between the two groups. Bladder mucosal damage occurred in 3 patients (4%) in the Versacut group, while mucosal bladder damage was not observed in any patient in the Hawk® JAWS group (p = 0.08). Conclusion: Hawk® JAWS and Lumenis® VersaCut morcellators were comparable in their efficiency and safety. Keywords: Hawk, HoLEP, morcellation, morcellator, Versacut.
- 21 February 2022
- Published by Pera Yayıncılık Hizmetleri in Yeni Üroloji Dergisi
- Vol. 17 (1) , 6-13
Hawk® JAWS versus Lumenis® VersaCut prostate morcellation devices: A comparative study and comprehensive literature review
Objective: Although morcellation is a standard procedure of Holmium Laser Enucleation of the Prostate (HoLEP), studies on the morcellators used are limited in number. We aimed to compare two different tissue morcellators used in HoLEP, which have similar objectives but differences in efficiency and safety in working principles. Material and Methods: The data of 130 patients who underwent HoLEP between December 2018 and December 2019 were retrospectively reviewed. Sixty-five patients received Lumenis® Versacut (Lumenis Inc., Santa Clara, CA, USA) morcellator and 65 patients received Hawk® JAWS (Hawk, Minitech Co., China) morcellator after enucleation were included in the study. The efficiency of morcellation (g/min), morcellation time (min), total operation time (min), enucleation time (min), enucleated tissue weight (g), the efficiency of enucleation, densities of the removed prostate tissues, perioperative complications associated with the use of a morcellator were recorded perioperatively. Results: There was no significant difference in total operation time (min), enucleation time (min), enucleated tissue weight (g), and efficiency of enucleation (g/min) efficiency of morcellation, morcellation time (min) between the two groups. Bladder mucosal damage occurred in 3 patients (4%) in the Versacut group, while mucosal bladder damage was not observed in any patient in the Hawk® JAWS group (p = 0.08). Conclusion: Hawk® JAWS and Lumenis® VersaCut morcellators were comparable in their efficiency and safety. Keywords: Hawk, HoLEP, morcellation, morcellator, Versacut.
- 1 December 2021
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 8 (4) , 261-265
Sacral Neuromodulation Treatment for Non-neurogenic Urological Disorders: Experience of a Single Center in Turkey
- 1 December 2021
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 8 (4) , 261-265
Sacral Neuromodulation Treatment for Non-neurogenic Urological Disorders: Experience of a Single Center in Turkey
- Open Access
- 20 June 2021
- Published by Pera Yayıncılık Hizmetleri in Yeni Üroloji Dergisi
- Vol. 16 (16-2) , 140-147
Single center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patients
Objective: We aimed to evaluate magnetic resonance imaging-ultrasound guided fusion prostate biopsy (MRI- US FPBx) results from a single center and to compare with current literature. Material and Methods: Between January 2016 and July 2019, MRI-US FPBx pathological and imaging results of 358 men were retrospectively analyzed. PI-RADS scores were determined as 3, 4 and 5 in 222 (62%), 107 (29.8%) and 29 (8.1%) patients, respectively. Totally 454 lesions were underwent MRI-US FPBx. 303 (66.7%) lesions were scored as PI-RADS 3, 120 (26.4%) lesions were scored as PI-RADS 4 and 31 (6.8%) lesions were scored as PI-RADS 5. 315 (69.3%) of lesions were in peripheral zone, 26 (5.7%) were in central zone, 111 (24.4%) were in transitional zone and 2 of them were in anterior fibromuscular stroma. Results: Overall prostate cancer detection rate was 36.3%. Concerning detection rates, MRI-US FPBx alone and transrectal ultrasonography guided prostate biopsy (TRUS-Bx) alone were 27.6% and 26.5%, respectively. Cancer detection rate only through MRI-US FPBx PIRADS-3 and PI-RADS 4&5 were 6.9% and 20.6%, respectively. Clinically significant prostate cancer (csPCa) rates were evaluated and csPCa to overall prostate cancer (PCa) rates for TRUS-Bx, MRI-US FPBx and combined techniques were 16.8%, 35.4% and 39.2%, respectively. Results of 11 patients were evaluated as benign. Conclusion: MRI-US FPBx significantly increases success rate of prostate biopsy procedure. Regarding current MRI technology, it is not appropriate to consider MRI-US FPBx as a stand-alone biopsy option without concomitant with TRUS-Bx. Keywords: prostate cancer; biopsy; MRI; fusion
- 20 June 2021
- Published by Pera Yayıncılık Hizmetleri in Yeni Üroloji Dergisi
- Vol. 16 (16-2) , 140-147
Open AccessSingle center results of magnetic resonance imaging ultrasound guided fusion prostate biopsy obtained patients
Objective: We aimed to evaluate magnetic resonance imaging-ultrasound guided fusion prostate biopsy (MRI- US FPBx) results from a single center and to compare with current literature. Material and Methods: Between January 2016 and July 2019, MRI-US FPBx pathological and imaging results of 358 men were retrospectively analyzed. PI-RADS scores were determined as 3, 4 and 5 in 222 (62%), 107 (29.8%) and 29 (8.1%) patients, respectively. Totally 454 lesions were underwent MRI-US FPBx. 303 (66.7%) lesions were scored as PI-RADS 3, 120 (26.4%) lesions were scored as PI-RADS 4 and 31 (6.8%) lesions were scored as PI-RADS 5. 315 (69.3%) of lesions were in peripheral zone, 26 (5.7%) were in central zone, 111 (24.4%) were in transitional zone and 2 of them were in anterior fibromuscular stroma. Results: Overall prostate cancer detection rate was 36.3%. Concerning detection rates, MRI-US FPBx alone and transrectal ultrasonography guided prostate biopsy (TRUS-Bx) alone were 27.6% and 26.5%, respectively. Cancer detection rate only through MRI-US FPBx PIRADS-3 and PI-RADS 4&5 were 6.9% and 20.6%, respectively. Clinically significant prostate cancer (csPCa) rates were evaluated and csPCa to overall prostate cancer (PCa) rates for TRUS-Bx, MRI-US FPBx and combined techniques were 16.8%, 35.4% and 39.2%, respectively. Results of 11 patients were evaluated as benign. Conclusion: MRI-US FPBx significantly increases success rate of prostate biopsy procedure. Regarding current MRI technology, it is not appropriate to consider MRI-US FPBx as a stand-alone biopsy option without concomitant with TRUS-Bx. Keywords: prostate cancer; biopsy; MRI; fusion
- Open Access
- 20 June 2021
- Published by Pera Yayıncılık Hizmetleri in Yeni Üroloji Dergisi
- Vol. 16 (16-2) , 184-189
Basic factors predicting prostate cancer in Prostate Imaging Reporting and Data System-3 lesions
Objective: We aimed to investigate the role of the digital rectal examination, PSA density, regional location of the lesion and prostate size in predicting prostate cancer in Prostate Imaging and Data Reporting System (PI-RADS)-3 lesions. Material and Methods: A total of 236 patients with multiparametric MRI performed for clinical suspicion of prostate cancer and reported PI-RADS-3 enrolled between January 2016 and July 2019 in this retrospective study. The datas were extracted from the hospital’s electronic records, patient files and outpatient clinic records. Multiparametric MRI was performed patients to whom have elevated PSA level and/or suspicious digital rectal examination. Patients diagnosed with and without prostate cancer were compared in terms of age, PSA, PSA density, prostate size, pathological results, lesion localization and DRE findings. Results: One hundred thirty- independent predictor seven patients with an initial score of PI-RADS-3 were subjected to further analysis. Prostat cancer detection rate in overall and clinically significant prostate cancer detection rate was 26.2% and 4.3%, respectively. There was a significant difference regarding DRE findings (p=0.001) and PZ location of the lesion (p=0.005) between PCa and no PCa groups. Digital rectal examination (p=0.001) was an independent predictor of prostate cancer in multivariate logistic regression analysis. Conclusion: Digital rectal examination is a practical and important parameter in clarifying the suspicion of prostate cancer in PI-RADS-3 lesions. Keywords: prostatic neoplasms, digital rectal examination, multiparametric magnetic resonance imaging, image guided biopsy
- 20 June 2021
- Published by Pera Yayıncılık Hizmetleri in Yeni Üroloji Dergisi
- Vol. 16 (16-2) , 184-189
Open AccessBasic factors predicting prostate cancer in Prostate Imaging Reporting and Data System-3 lesions
Objective: We aimed to investigate the role of the digital rectal examination, PSA density, regional location of the lesion and prostate size in predicting prostate cancer in Prostate Imaging and Data Reporting System (PI-RADS)-3 lesions. Material and Methods: A total of 236 patients with multiparametric MRI performed for clinical suspicion of prostate cancer and reported PI-RADS-3 enrolled between January 2016 and July 2019 in this retrospective study. The datas were extracted from the hospital’s electronic records, patient files and outpatient clinic records. Multiparametric MRI was performed patients to whom have elevated PSA level and/or suspicious digital rectal examination. Patients diagnosed with and without prostate cancer were compared in terms of age, PSA, PSA density, prostate size, pathological results, lesion localization and DRE findings. Results: One hundred thirty- independent predictor seven patients with an initial score of PI-RADS-3 were subjected to further analysis. Prostat cancer detection rate in overall and clinically significant prostate cancer detection rate was 26.2% and 4.3%, respectively. There was a significant difference regarding DRE findings (p=0.001) and PZ location of the lesion (p=0.005) between PCa and no PCa groups. Digital rectal examination (p=0.001) was an independent predictor of prostate cancer in multivariate logistic regression analysis. Conclusion: Digital rectal examination is a practical and important parameter in clarifying the suspicion of prostate cancer in PI-RADS-3 lesions. Keywords: prostatic neoplasms, digital rectal examination, multiparametric magnetic resonance imaging, image guided biopsy
- 31 May 2021
- Published by Hindawi Limited in Andrologia
- Vol. 53 (8) , e14137
Is ‘Omega Sign’ anatomical endoscopic enucleation of the prostate technique reproducible?
We aimed to evaluate the learning curve of the surgically standardised ‘Omega Sign’ anatomical endoscopic enucleation (AEEP) of the prostate surgery technique for junior surgeons. This study is a retrospective comparison of cases that underwent AEEP by a mentor surgeon and three junior surgeons who have completed their learning curve. A video-based laser enucleation of the prostate assessment tool (LEAT) composed of 8 steps of the technique was used to assess a senior surgeon and junior surgeons’ surgical compatibility and consistency. The surgeon who defined Omega Sign technique was determined as group 1, and cases by three junior surgeons were identified as group 2. The end points were to assess the reproducibility and repeatability and operative post-operative outcomes of the technique. 55 patients’ videos were rated by five experienced endourologists. There was no significant difference in LEAT scores between the groups among all steps. The most symmetry was found in the 1st and 3rd steps. Inter-rater consistency was also high for each step, with no statistically significant difference between the evaluators. The standardised anatomical ‘Omega Sign’ technique is reproducible for the junior surgeons. The operative steps can be performed with high consistency, and the functional and perioperative outcomes are comparable with the senior surgeon.
- 31 May 2021
- Published by Hindawi Limited in Andrologia
- Vol. 53 (8) , e14137
Is ‘Omega Sign’ anatomical endoscopic enucleation of the prostate technique reproducible?
We aimed to evaluate the learning curve of the surgically standardised ‘Omega Sign’ anatomical endoscopic enucleation (AEEP) of the prostate surgery technique for junior surgeons. This study is a retrospective comparison of cases that underwent AEEP by a mentor surgeon and three junior surgeons who have completed their learning curve. A video-based laser enucleation of the prostate assessment tool (LEAT) composed of 8 steps of the technique was used to assess a senior surgeon and junior surgeons’ surgical compatibility and consistency. The surgeon who defined Omega Sign technique was determined as group 1, and cases by three junior surgeons were identified as group 2. The end points were to assess the reproducibility and repeatability and operative post-operative outcomes of the technique. 55 patients’ videos were rated by five experienced endourologists. There was no significant difference in LEAT scores between the groups among all steps. The most symmetry was found in the 1st and 3rd steps. Inter-rater consistency was also high for each step, with no statistically significant difference between the evaluators. The standardised anatomical ‘Omega Sign’ technique is reproducible for the junior surgeons. The operative steps can be performed with high consistency, and the functional and perioperative outcomes are comparable with the senior surgeon.